PERICARDIAL EFFUSION MALIGNANT side effect
What is PERICARDIAL EFFUSION MALIGNANT ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
PERICARDIAL EFFUSION MALIGNANT and Recently Reported Side Effects
PERICARDIAL EFFUSION MALIGNANT and 15 most Active Side Effect polls
PERICARDIAL EFFUSION MALIGNANT and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Lapatiniblet Side Effects Report #5640116-5
Physician from AUSTRIA reported LAPATINIBLET problem on Feb 11, 2008. Female patient, 55 years of age, weighting 173.1 lb, was diagnosed with breast cancer metastatic and was treated with LAPATINIBLET. After drug was administered, patient experienced the following problems/side effects: disease progression, pericardial effusion malignant, . LAPATINIBLET dosage: unknown. During the same period patient was treated with CAPECITABINELET. Patient was hospitalized. Patient recovered.
Lapatinib Side Effects Report #5645320-8
LAPATINIB problem was reported by a Physician from AUSTRIA on Feb 26, 2008. Female patient, 55 years of age, weighting 173.5 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pericardial effusion malignant, pulmonary embolism, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5565851-9
Pharmacist from GERMANY reported TARCEVA problem on Dec 05, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, pericardial effusion malignant, . TARCEVA dosage: unknown. Patient recovered.